Conavi Medical Corp.
CNVI.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 61.39% | 58.17% | 72.97% | -- | 5.69% |
| Total Depreciation and Amortization | -16.02% | 24.21% | -17.57% | -- | -22.97% |
| Total Amortization of Deferred Charges | -- | -82.15% | -- | -- | -- |
| Total Other Non-Cash Items | -234.87% | -77.23% | -120.09% | -- | -135.24% |
| Change in Net Operating Assets | 153.34% | -141.07% | -212.17% | -- | -1,714.13% |
| Cash from Operations | 51.16% | -10.45% | -40.23% | -- | -65.93% |
| Capital Expenditure | -3.86% | 93.14% | 94.55% | -- | 81.78% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -103.09% | -87.25% | 100.00% | -- | 3,883.29% |
| Cash from Investing | -103.92% | 51.92% | 95.86% | -- | 1,539.60% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -12.79% | -77.06% | -91.93% | -- | -58.09% |
| Issuance of Common Stock | -- | -- | -- | -- | 336,300.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -105.04% | -110.70% | 301.06% | -- | 3,591.30% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -205.07% | -311.36% | 965.41% | -- | 180.40% |